Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T04:13:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T22:30:20.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding 2 more study numbers and indicating that the study has 1 location, while the previous version v2.9.7 has been removed.
    Difference
    0.4%
    Check dated 2024-07-23T14:12:44.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:17:18.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-11T00:43:52.000Z thumbnail image
  9. Check
    66 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-09T23:56:35.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.